Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.

Krieger, K; Heine, J; Dumont, P; Hellmann, K

Krieger, K; Heine, J; Dumont, P; Hellmann, K.

Affiliation

Krieger K; Bayer HealthCare AG, Animal Health, R&D Parasiticides, 51368, Leverkusen, Germany. klemens.krieger@bayerhealthcare.com.
Heine J; Bayer HealthCare AG, Animal Health, R&D Parasiticides, 51368, Leverkusen, Germany.
Dumont P; Datavet S.A., 48 impasse des Eglantiers, 34980, Saint Clement de Riviere, France.
Hellmann K; Klifovet AG, Geyerspergerstrasse 27, 80689, München, Germany.

Parasitol Res ; 97 Suppl 1: S81-S88, 2005 10.

Article in En | MEDLINE | ID: mdl-16228280

Subject(s)

Dog Diseases/drug therapy; Imidazoles/administration & dosage; Imidazoles/therapeutic use; Mite Infestations/veterinary; Nitro Compounds/administration & dosage; Nitro Compounds/therapeutic use; Administration, Topical; Animals; Dogs; Drug Therapy, Combination; Ear Diseases/parasitology; Ear Diseases/veterinary; Female; Insecticides/administration & dosage; Insecticides/therapeutic use; Ivermectin/analogs & derivatives; Ivermectin/therapeutic use; Macrolides/administration & dosage; Macrolides/therapeutic use; Male; Mite Infestations/drug therapy; Neonicotinoids

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dog Diseases / Imidazoles / Mite Infestations / Nitro Compounds Limits: Animals Language: En Journal: Parasitol Res Journal subject: PARASITOLOGIA Year: 2005 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google